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Abstract:  The article considers contemporary systems for controlled delivery of active 
agents, such as drugs, agricultural chemicals, pollutants and additives in the environment. A 
useful classification of the available controlled release systems (CRS) is proposed according 
to the type of control (passive, active or self-preprogrammed) and according to the main 
controlling mechanism (diffusion, swelling, dissolution or erosion). Special attention is given 
to some of the most used CRS – polymer monoliths. The structural and physical-chemical 
characteristics of CRS as well as the basic approaches to their production are examined. The 
basic mechanisms of controlled agent release are reviewed in detail and factors influencing 
the release kinetics are classified according to their importance. The present study can be 
helpful for understanding and applying the available mathematical models and for 
developing more comprehensive ones intended for design of new controlled delivery systems. 
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Introduction 
The design and investigation of active agent delivery systems is a multidisciplinary area 
which has attracted interest from various investigators – mechanical and chemical engineers, 
ecologists, pharmacists, physicians and others, over the last two decades. The possible 
applications of these systems include release of drugs, agriculture chemicals and pollutants 
from polymers, as well as additives from photoresist technology and microlithography into 
the environment [3, 8, 14, 18, 25, 26, 27, 30]. 
 
The traditional delivery systems are characterized by immediate and uncontrolled release 
kinetics of the delivered active agent. The drug release for example, usually undergoes a sharp 
increase in concentration followed by a similar decrease in concentration that may causes a 
dangerous approach to the toxic threshold or fall down below the effective therapeutic level 
[8]. 
 
The purpose of the contemporary delivery systems, or so called controlled release systems 
(CRS), is to maintain the agent concentration in the target medium at a desired value and to 
assure a control of the release rate and of the duration of the agent [9, 18, 26]. BIO
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The object of the present considerations is controlled drug delivery systems, the design and 
production of which has been rapidly developing especially in the pharmaceutical industry 
(pills, implants, spray form drugs etc). Controlled drug release systems are of critical 
importance for the implementation of contemporary therapeutic treatment, which places a 
stress on drug effectiveness and patient compliance. The design of new more effective CRS 
brings engineers and pharmacists to work together with a common aim. The development of 
appropriate mathematical models predicting the realization of the drug delivery is an 
important and necessary activity for the design of CRS. Mathematical modeling is performed 
under reasonable assumptions for the structural characteristics of the systems and for the 
mechanisms of the transfer and physicochemical processes during the drug release. 
 
The aim of the present study is to analyze and systemize the available information for the 
basic characteristics and mechanisms of the CRS from the point of view of mathematical 
modeling of controlled agent delivery. 
 
General classification of CRS 
Three different categories of CRS can be distinguished: passive preprogrammed, active 
preprogrammed and active self-programmed [16, 24]. While in the first category the release 
rate is predetermined and is irresponsive to external biological stimuli, in the second category 
it can be controlled by a source external to the body as in the case of insulin delivery. The last 
category which has the greatest potential of the three is characterized by the possibility of 
self-control induced by biological stimuli such as sugar concentration in the blood. 
 
Two major types of biocompatible materials are used for designing such systems: inorganic 
(metals, ceramics and glasses) and polymeric (synthetic and natural) [15]. The most common 
mechanism that controls the drug delivery is diffusion. Two kinds of diffusion controlled 
systems have been developed. The first is a reservoir system in which the bioactive agent 
represents a core surrounded by an inert diffusion barrier (Fig. 1), such as a membrane, a 
capsule, a microcapsule, a liposome, fiber. The second type is a monolithic system in which 
the active agent is dispersed or dissolved in an inert polymer and its release is controlled 
mainly by the diffusion as shown schematically on Fig. 2. Chemical control can also be 
achieved using: biodegradable (bioerodible) systems (see Fig. 3) in which the polymeric 
matrix converses from insoluble in water into soluble one or pendant chain systems where the 
drug is covalently bound to the polymer. 
 
 
 
Fig. 1 Schematic representation of reservoir diffusion controlled release systems BIO
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Fig. 2 Schematic representation of monolithic diffusion controlled release systems 
 
Fig. 3 Schematic representation of biodegradable release systems 
 
Having in mind the large diversity of CRS applications (in contraception, ophthalmic and 
odontoiatric field, cancer, alcoholism or diabetes treatment e.g.) we can conclude that a 
complete description of such systems is a heavy task in the frame of the present paper. We 
focus our attention on a set of the most used CRS – monolithic or matrix systems. 
 
Monolithic systems. Basic Characteristics. 
From an engineering point of view, the term “matrix” indicates a three-dimensional network, 
more often polymeric, fabricated for a particular application and containing an active agent 
(drug) and other substances such as solvents and excipients. The matrices can be hydrophilic 
(such as hydroxypropyl methylcellulose – HPMS, methylcellulose, sodium carboxymethyl-
cellulose, alginates and scleroglucan) or hydrophobic (such as wax, polyethylene, 
polypropylene and ethylcellulose) [16, 30].  
 
There are three main approaches for preparation of polymer monolithic systems [8]. The first 
one is based on mixing the drug, as a thin powder, with the prepolymer and subsequently 
placing the whole mixture in the polymerization reactor. A matrix can be prepared in advance 
and then put in contact with a highly concentrated drug solution able to swell the matrix. The 
solvent is then removed, for example by a physical treatment.  
 
The second approach is based on mechanic-chemical activation, which allows the loading of a 
drug into a polymeric carrier, thus avoiding the use of solvents whose elimination can be very 
expensive and delicate operation. Additionally, matrices can be drug-loaded using 
supercritical fluid techniques. The supercritical fluids are dense as liquid but viscous as gas, BIO
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and easily swell the matrix (bringing the drug inside the matrix or extracting solvents) and can 
be later removed by decreasing pressure. 
 
The simplest way for preparing a monolithic system is to compress, in a proper ratio, the 
polymer, the drug and the required excipients. 
 
The newest CRS are connected with nanotechnologies and consist of nano or micro particles 
containing an active agent implemented in a biodegradable polymeric matrix [32]. 
 
Although polymeric matrices are characterized by different physical and chemical properties 
(neutral, polyelectrolyte, liphophilic e.g.), they posses the same structural characteristics [9, 
20]. They can be considered as coherent systems with mechanical characteristics in between 
those of solids and liquids, and as made up by a continuum medium in which high molecular 
weight molecules are dispersed and collocated to form a continuum three dimensional 
network [20]. The presence of crosslinks between the polymeric chains hinders polymer 
dissolution in the liquid phase that can only swell the network. In the case of strong crosslinks 
(typically chemical covalent bonds) the network does not change over time that is as opposed 
to the case of prevailing weak crosslinks (typically physical interactions such as Coulombic, 
van der Waals, dipole-dipole etc.). Distribution of the crosslinks is time-dependent due to 
Brownian motion of the chains and segments of chains even when the crosslink density is 
constant with time. As a consequence, each network can undergo erosion depending on the 
polymer-polymer junction weakness. The picture is more complex when the matrix is 
constituted by an ensemble of small matrix domains embedded in a continuum.  
 
There exist also contemporary matrices with two networks (interpenetrating structures) 
originated by two different polymers [17]. These matrices are produced by an initial swelling 
of a monomer, followed by a reaction to form a second intermeshing network.  
 
According to the porosity, matrix systems can be classified as follows: macro porous with 
pores dimension between 0,1-1µm; micropores with pores dimension between 50-200 Ǻ, 
slightly larger than diffusant molecules size; non porous [16]. In the first two categories drug 
diffusion occurs essentially through pores, while in nonporous systems the drug molecules 
diffuse through network mesh.  
 
Polymer matrices may gain anisotropy in the process of their manufacturing due to operations 
predominant in one direction (tablets compression is performed in the axial direction e.g.) 
[33]. The matrix particles may deform more in one direction, which may induce dissimilar 
residual stresses and change the porosity, tortuosity and geometric obstructions differently in 
different directions. Thus the anisotropic structure of the pores can affect the drug diffusion 
coefficient in different directions. 
 
According to some studies, in certain crystals and polymer sheets, the molecules have a 
preferential orientation which can result in anisotropic behavior [33]. It has been established 
that the rate of solvent penetration in a direction parallel to the orientation axis is less than the 
rate of penetration in the perpendicular direction, which is due to the anisotropic diffusion 
coefficients of the penetrant.  
 
 
 BIO
Automation
Bioautomation, 2006, 4, 80 - 88  ISSN 1312 – 451X 
 
  84
Mechanisms of controlled agent release from the matrix 
Except in some rare cases, matrix systems are stored in dry, shrunken state (without any 
liquid phase inside) before usage, due to stability and dosing requirements [8, 10]. In that state 
of the matrix, the drug is in the form of microcrystal, of nanocrystals or in an amorphous 
state, diffusion through the network meshes dose not exist [21], and the state is known as a 
”glassy” one [10]. Upon contact with the release fluids (water or physiological media) 
penetrating from the surroundings the matrix begins to swell and drug dissolution can take 
place (for polymers with a transition temperature higher than room temperature). The process 
of swelling implies the transition from a glassy state to a “rubbery”, swollen one. As soon as 
the liquid penetrant concentration exceeds a threshold value, the polymer chains unfold and as 
a consequence of the above mentioned transition, a gel-like layer, surrounding the matrix dry 
core, begins to appear [9]. This transition implies a molecular rearrangement of the polymeric 
chains that tend to reach a new equilibrium condition. The time required for this 
rearrangement denoted by  r t , commonly depends on the temperature and on the concentration 
of the penetrating solute [10]. When  r t  is much greater than the characteristic (relaxation) 
time of diffusion  d t  (defined as the ratio of the diffusion coefficient of the penetrating solvent 
at equilibrium and the square of a characteristic length of the matrix), then the Fickian solvent 
diffusion [6] with constant diffusivity takes place. If  r t  is much lower than  d t , the solvent 
penetration may be described by means of Fick’s law with concentration dependent 
diffusivity. When  d r t t ≈  (up to second exponent order of their ratio), the penetrant 
absorption does not follow the classical Fikcian law [2, 9, 28, 29]. In this case the 
macroscopic release of the drug becomes anomalous or non classical [6], while in the other 
cases it behaves classically, despite the fact that drug release rate usually depends on the 
solvent concentration distribution. The last dependency can be accounted by the drug 
diffusivity. 
 
The glassy-rubbery transition significantly increases polymer chain mobility, so that the 
network mesh enlarges and the drug can dissolve and diffuse through the gel layer. 
Nanocristal and amorphous drugs are characterized by a higher solubility in aqueous medium 
with respect to the microcrystal drug (especially for radius smaller than 10 nm), as solubility 
depends on crystal size. An inverse process of re-crystallization occurs simultaneously due to 
the lack of thermodynamic equilibrium with unavoidable solubility reduction. Dissolved drug 
re-crystallization can take place inside the matrix but also in the release environment during 
the release process. This phenomenon can be characterized by different re-crystallization 
constants (for details see [11]). 
 
Drug diffusion through the swelling network system depends on polymer/drug physical-
chemical characteristics as adsorption and desorption processes are possible on the polymer 
chains [12]. It depends also on the ratio between the diffusant and mesh size as well as on the 
matrix topology. Matrix systems can be considered as fractal media for their internal high 
disorder degree due to complex network topology. It can be demonstrated the diffusion 
process through fractal (percolative) networks differs a lot from diffusion in non fractal 
networks [1]. 
 
The initial drug distribution in the matrix (the concentration profile) can significantly 
influence the release kinetics. It is established [22] that very different release kinetics can be 
achieved by selecting uniform, sigmoidal, steps or parabolic drug concentration. In the case of 
uniform distribution the dissolution of the drug present at the matrix/release environment BIO
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interface can give origin to a burst effect in the release profile followed by a slower release 
[8]. This effect is observed more significantly in hydroxypropyl methylcellulose (HPMC) 
matrix systems characterized by a high swellability [26]. 
 
According to Langer and Peppas [19], diffusion, swelling and erosion are the most important 
rate-controlling mechanisms of commercially available CRS. Nevertheless, dissolution and 
other possible physicochemical interactions can influence CRS behavior in a different extent. 
When investigating the simultaneous processes in a matrix system two different diffusion 
types processes should be distinguished – penetration of the external fluid into the matrix 
(penetrant uptake) and the drug release from the matrix. The penetrant uptake gives origin to 
the formation of three fronts [4, 5, 8] (as it is shown on Fig. 4). The eroding front is the outer 
interface which separates the matrix from the release environment. It moves outwards when 
swelling kinetics is predominant on the erosion process or inwards when erosion is 
predominant. The position of this front depends on the environment influence as well as 
structural and physicochemical properties of the matrix. The swelling front, separating the 
glassy core from the swelling area, moves inward and its rate depends on the polymer/solvent 
system characteristics (namely, the viscous-elastic properties of the system). In porous 
matrices this front depends on the system porosity also.  
 
Fig. 4 Three fronts induced by the external fluid penetration:  
the swelling front, the diffusion front and the erosion front 
 
In the case of a dissolvable drug, an additional front appears in the swelling area, namely the 
diffusion front. It separates the part of the matrix, where the drug is dissolved, from that of the 
undissolved (dispersed) drug and follows the swelling front in its motion. When drug 
diffusion is much slower than its dissolution, drug release is accepted to be diffusion 
controlled [15, 33]. Usually it is assumed drug dissolution is realized very rapidly in respect 
to the rate of its release and the main control is performed on diffusion. There exist few 
investigations accounting the effect of the finite drug dissolution rate [5, 7]. The role of 
dissolution and diffusion increases with decreasing of the matrix swelling degree, especially 
in porous matrices [13]. 
 
The scheme on Fig. 4 is a simplified consideration of the real mechanisms of the controlled 
drug release. The results from the numerical simulations of the considered processes [2, 6, 7, BIO
Automation
Bioautomation, 2006, 4, 80 - 88  ISSN 1312 – 451X 
 
  86
9, 22, 23, 26, 28, 29, 31, 32] show that except for rare cases, both solvent and drug 
concentrations have a sigmoidal profile in the matrix rather than a steps profile. Nevertheless 
this scheme can be very useful in understanding the whole complex of interconnecting 
processes.  
 
On the basis of the above considerations we can conclude that the most important factors 
(processes and parameters) for drug release kinetics are as follows: 
•  mass transfer of the penetrating solvent (Fickian or non-Fickian diffusion); 
relaxation time of the penetrant diffusion and polymer transition relaxation 
time; 
•  agent release as Fickian diffusion with diffusivity dependent on the solvent 
concentration;  
•  degree of matrix swelling due to penetrating solvent; 
•  degree of matrix erosion; 
•  agent dissolution rate and its solubility limit; 
•  matrix geometry (planar, cylindrical, spherical and others); 
•  structural characteristics (such as porosity, distribution of the initial agent 
loading) and degree of anisotropy;  
•  physicochemical interactions and parameters of the polymer-agent system. 
 
Generalizing, the agent release behavior can be considered as a function of the above factors 
if each type of CRS is defined by a set of characteristic values and appropriate operators, 
representing quantitatively the processes in the system. The detailed evaluation of the domain 
of this function is an object of next considerations. 
 
Conclusion 
A systematic review of the contemporary systems for controlled delivery of active agent has 
been performed. After some basic classifications according to the type of control, the widely 
used monolithic CRS have been chosen as a main object under considerations. 
 
The structural and physical-chemical characteristics of polymeric matrix CRS as well as the 
basic approaches to their production are studied. All key mechanisms that undergo in the 
monolithic CRS are analyzed and a useful classification of the factors influencing the active 
agent release kinetics is derived. 
 
The present study can serve as a basis when applying the proposed so far mathematical 
models and when developing more comprehensive ones, intended for design of contemporary 
monolithic controlled drug delivery systems. 
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